All In Biotech

Drug Trial Radar · NCT07015918

A Study to Understand How the Study Medicine (PF-07976016) is Processed and Eliminated in Healthy Men

A PHASE 1, OPEN-LABEL, 2-PERIOD, FIXED-SEQUENCE STUDY TO INVESTIGATE THE ABSORPTION, DISTRIBUTION, METABOLISM, AND EXCRETION OF [14C]PF-07976016 AND TO ASSESS THE ABSOLUTE BIOAVAILABILITY AND FRACTION ABSORBED OF PF-07976016 IN HEALTHY MALE PARTICIPANTS USING A [14C]-MICROTRACER APPROACH

Last checked: Nov 19, 2026Latest source record: Sep 10, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

8

Actual

Start

Jun 4, 2025

Primary completion

Jul 16, 2025

Study completion Aug 14, 2025

Sponsor

Lead sponsor
PfizerPfizer (PFE)
Sponsor type
Industry
First posted
Jun 11, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Basic science
FDA-regulated drug
Yes
Who can join
Male only, from 18 years, up to 65 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

The purpose of this study is to learn about how much the study medicine PF-07976016 will be taken up and processed by healthy male participants. The total number of weeks of the study is up to approximately 12 weeks.

Conditions

  • Healthy Male Volunteers

Interventions

  • [14C] PF-07976016Drug

    \[14C\] PF-07976016 liquid (oral) formulation

  • PF-07976016Drug

    PF-07976016 liquid (oral) formulation

  • [14C] PF-07976016Drug

    \[14C\] PF-07976016 intravenous (IV) formulation

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Total recovery of radioactivity expressed as a percent of total oral radioactive dose administered.Time frame: From dose (Day 1) and for up to 21 days thereafter

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • ICON

    Groningen, Netherlands

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.